PCN67 COST-EFFECTIVENESS ANALYSIS OF DARATUMUMAB PLUS...

PCN67 COST-EFFECTIVENESS ANALYSIS OF DARATUMUMAB PLUS BORTEZOMIB AND DEXAMETHASONE VERSUS BORTEZOMIB AND DEXAMETHASONE FOR TREATMENT OF PATIENTS WITH MULTIPLE MYELOMA WHO HAVE RECEIVED AT LEAST ONE PRIOR THERAPY IN PORTUGAL

Paquete, A.T., Gouveia, M., Guerreiro, R., Anjo, J., Magalhaes, C., Borges, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
22
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.09.264
Date:
November, 2019
File:
PDF, 318 KB
2019
Conversion to is in progress
Conversion to is failed